Latest news with #HospitalAuthority
The Star
2 days ago
- Health
- The Star
Faulty prostate cancer tests leave 406 Hong Kong patients with nervy wait
Hong Kong public hospitals are reviewing blood test results of more than 400 patients after batches of a reagent were found to have quality issues that could produce false positives for prostate cancer. The Hospital Authority said on Tuesday that it was following up with the supplier of a testing product after being notified by the firm last week about complaints elsewhere related to quality issues. Billed as RM9.73 for the 1st month then RM13.90 thereafters. RM12.33/month RM8.63/month Billed as RM103.60 for the 1st year then RM148 thereafters. Free Trial For new subscribers only
South China Morning Post
7 days ago
- General
- South China Morning Post
Faulty prostate cancer tests leave 406 Hong Kong patients with nervy wait
Hong Kong public hospitals are reviewing blood test results of more than 400 patients after batches of a reagent were found to have quality issues that could produce false positives for prostate cancer Advertisement The Hospital Authority said on Tuesday that it was following up with the supplier of a testing product after being notified by the firm last week about complaints elsewhere related to quality issues. The product, supplied by Abbott Laboratories, is a reagent kit that detects the level of prostate-specific antigen (PSA) in blood. An elevated level may be a sign of prostate cancer. The product's quality issues could 'potentially lead to a misdiagnosis of prostate cancer, causing doctors to erroneously consider unnecessary treatments', the authority said. Two batches of the affected products were sent to Caritas Medical Centre in Sham Shui Po and Tuen Mun Hospital. Advertisement While Tuen Mun Hospital had not started to use the product, Caritas Medical Centre had already tested blood samples of 406 patients with the PSA kit since April 28. It has reviewed the test results and will contact about 70 patients this week, and rearrange blood tests based on their clinical needs.
South China Morning Post
28-05-2025
- General
- South China Morning Post
Pilot scheme offers hope to Hong Kong patients with degenerative knee disease
Hong Kong's public hospitals are offering more patients with a degenerative knee condition an extra treatment option combining Western and Chinese medicine to relieve pain and slow down deterioration amid a long queue for joint replacement surgery. The Hospital Authority said the pilot scheme targeting knee osteoarthritis, which was launched in May last year, was its first integrated Chinese-Western medicine outpatient service and had been expanded to Pamela Youde Nethersole Eastern, Queen Elizabeth, United Christian and Yan Chai hospitals. Dr Wun Yiu-chung, chairman of the authority's Coordinating Committee in Orthopaedics and Traumatology, said that with an ageing population in Hong Kong, knee osteoarthritis was one of the most common orthopaedic conditions and such cases had been on the rise. 'As the disease will become more common, it will be a huge challenge for the healthcare system. Thus, our goal is to maintain and improve the quality of life for the elderly,' said Wun, who is also the chief of service in orthopaedics and traumatology for hospitals in the New Territories West area. 'There are many successful and valuable experiences in mainland China by using the concepts of step-up therapy and chronic disease management to help patients with knee osteoarthritis at different levels. We established the integrated service after learning from these valuable experiences.'
South China Morning Post
27-05-2025
- General
- South China Morning Post
Pilot scheme offers hope to Hong Kong patients with degenerative knee disease
Hong Kong's public hospitals are offering more patients with a degenerative knee condition an extra treatment option combining Western and Chinese medicine to relieve pain and slow down deterioration amid a long queue for joint replacement surgery. The Hospital Authority said the pilot scheme targeting knee osteoarthritis, which was launched in May last year, was its first integrated Chinese-Western medicine outpatient service and had been expanded to Pamela Youde Nethersole Eastern, Queen Elizabeth, United Christian and Yan Chai hospitals. Dr Wun Yiu-chung, chairman of the authority's Coordinating Committee in Orthopaedics and Traumatology, said that with an ageing population in Hong Kong, knee osteoarthritis was the most common orthopaedic condition and such cases had been on the rise. 'As the disease will become more common, it will be a huge challenge for the healthcare system. Thus, our goal is to maintain and improve the quality of life for the elderly,' said Wun, who is also the chief of service in orthopaedics and traumatology for hospitals in the western New Territories. 'There are many successful and valuable experiences in mainland China by using the concepts of step-up therapy and chronic disease management to help patients with knee osteoarthritis at different levels. We established the integrated service after learning from these valuable experiences.'
South China Morning Post
27-05-2025
- Health
- South China Morning Post
Legal obstacles stymie mechanism on organ donation between Hong Kong, mainland China
Legal hurdles remain a reason why a proposed regular mechanism on organ donation between Hong Kong and mainland China has yet to materialise since discussions started in 2022, according to a top health official from the country. Wang Haibo, director of the China Organ Transplant Response System (COTRS), told the Post on the sidelines of the Hospital Authority Convention on Tuesday that it would take time to revise laws on the mainland to spur the establishment of the mechanism. 'There is a legal hurdle for that,' Wang said. 'We have the HIV regulation. We ban [the transfer of] organs across the border.' 'Organ, blood and tissue … cannot [be transferred] across the border.' COTRS is a national system which allocates organs for transplants throughout the country. Wang said that the specific law that stymied the development of the cross-border mechanism was related to controls to prevent the spread of HIV.
